Codexis, Inc.
$1.55 +$0.07 (+4.73%) 1D After hoursKey Metrics
The Story So Far
LAST 6 MONTHS PRIMARY SOURCES ONLY-
Jul 24
Offering paper hit the record (Form 424B5).
424B5 - CODEXIS, INC. (0001200375) (Filer)
RECEIPT: SEC FORM 424B5, TIMESTAMPED -
Jul 24
From its May 8 high, the share price fell 48%.
Peak close $2.85 on May 8; trough close $1.48 on Jul 24. The drawdown is the fact — the chapters around it are the context.
RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -48% -
Jul 24
The stock moved -25.6% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Jul 24 -
Jul 23
Offering paper hit the record (Form 424B5).
424B5 - CODEXIS, INC. (0001200375) (Filer)
RECEIPT: SEC FORM 424B5, TIMESTAMPED -
Jul 23
A material event was filed (Form 8-K).
8-K - CODEXIS, INC. (0001200375) (Filer)
RECEIPT: SEC FORM 8-K, TIMESTAMPED -
Jul 16
Money rotated out of high-beta cohorts market-wide.
High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.
RECEIPT: ROTATION GAUGE, LIVE -
Mar 12
The stock moved +34.6% in a single session.
Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.
RECEIPT: DAILY BAR, Mar 12
The story updates itself as events post · The wolf reports; you decide
Snapshot
About Codexis, Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis.
Wolf Grade COMING SOON
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.